WDR68 Inhibitors

The concept of WDR68 (DDB1- and CUL4-associated factor 7) inhibitors encompass a group of compounds that indirectly influence the activity or the pathways associated with WDR68. As a multifunctional protein involved in craniofacial development, skin development, and possibly acting as a substrate receptor for the CUL4-DDB1 E3 ubiquitin-protein ligase complex, WDR68's direct inhibition is complex and not well-established. Therefore, the focus is on targeting related pathways and processes. Given WDR68's association with the GLI1 transcriptional activity and the Hedgehog (Hh) signaling pathway, inhibitors of this pathway, such as Cyclopamine, Vismodegib, and Sonidegib, are of particular interest. These compounds can indirectly influence WDR68-related functions by modulating GLI1 activity, which plays a crucial role in developmental processes and cell differentiation. GANT61, a direct GLI1 inhibitor, further emphasizes this approach by targeting the downstream effectors of the Hh pathway. In the context of WDR68's role in the ubiquitin-proteasome system, proteasome inhibitors like MG-132 [Z-Leu- Leu-Leu-CHO] and Bortezomib are relevant. These agents can affect protein degradation pathways, influencing processes in which WDR68 is involved. Additionally, compounds like MLN 4924, which inhibits NEDD8-activating enzyme, could affect the function of the CUL4-DDB1 complex, further linking to WDR68's activity. Thalidomide and its analogs, Lenalidomide and Pomalidomide, known for modulating ubiquitin ligase activity, present another avenue to indirectly affect WDR68-related pathways. These immunomodulatory compounds have been shown to impact various aspects of cell signaling and may have implications for pathways involving WDR68. Furthermore, considering WDR68's role upstream of the EDN1 pathway in craniofacial development, endothelin-1 antagonists like Bosentan could indirectly influence WDR68-related developmental processes. Lastly, Spautin-1, an inhibitor of USP10, is included due to its impact on ubiquitination and degradation pathways associated with WDR68. In summary, the approach to targeting WDR68 involves a combination of compounds affecting crucial signaling pathways, such as the Hedgehog pathway and the ubiquitin-proteasome system.